Patrick Phelps2025-10-13T13:30:37+00:00SOFIE network expands production of 18F-FAPI-74Patrick Phelps2025-10-13T13:30:37+00:0015, Jan 2025|
Patrick Phelps2025-10-15T16:42:10+00:00SOFIE and GE HealthCare SNMMI Symposium highlights FAP targetingPatrick Phelps2025-10-15T16:42:10+00:0012, Jun 2024|
Patrick Phelps2025-10-13T13:31:06+00:00Trilantic North America Completes Strategic Growth Investment in SOFIE BiosciencesPatrick Phelps2025-10-13T13:31:06+00:004, Jun 2024|
Patrick Phelps2025-10-15T16:42:11+00:00[18F]FAPI-74 serving as complementary diagnostic in Avacta Phase 1 trialPatrick Phelps2025-10-15T16:42:11+00:0023, May 2024|
Patrick Phelps2025-10-15T16:42:14+00:00SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET RadiotracersPatrick Phelps2025-10-15T16:42:14+00:0011, Oct 2023|
Patrick Phelps2025-10-15T16:42:11+00:00FAP symposium another success at 2023 SNMMI meetingPatrick Phelps2025-10-15T16:42:11+00:007, Jul 2023|
